SEC Form 4 · accession 0001273636-18-000028
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Scott Koenig
Director
Period of report
Jul 25, 2018
Accepted (ET)
Jul 27, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.25 | Jul 25, 2018 | A | 8,000 | A | — | Jul 25, 2028 | Common Stock | 8,000 | 8,000 | D |
Explanation of responses
- F1The option becomes exercisable on July 25, 2019.